These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 3746260)
1. Use of N-acetylethyleneimine [AEI] for the inactivation of Semliki Forest virus in vitro. Amor S; Webb HE J Med Virol; 1986 Aug; 19(4):367-76. PubMed ID: 3746260 [TBL] [Abstract][Full Text] [Related]
2. Preparation of inactivated vaccines against alphaviruses using Semliki Forest virus-white mouse as a model. I. Inactivation experiments and evaluation of double inactivated subunit vaccines. Mussgay M; Weiland E Intervirology; 1973; 1(4):259-68. PubMed ID: 4775474 [No Abstract] [Full Text] [Related]
3. A vaccine against Semliki Forest virus consisting of a monoclonal anti-idiotypic antibody cross-linked to a protein which contains virus-specific T-helper cell epitopes. Kraaijeveld CA; Oosterlaken TA; Snijders A; Benaissa-Trouw BJ; Ekstijn GL; Snippe H Antiviral Res; 1992 Oct; 19(4):275-84. PubMed ID: 1281391 [TBL] [Abstract][Full Text] [Related]
4. Antibody response to spike protein vaccines prepared from Semliki Forest virus. Balcarova J; Helenius A; Simons K J Gen Virol; 1981 Mar; 53(Pt 1):85-92. PubMed ID: 6268742 [TBL] [Abstract][Full Text] [Related]
5. IgVH determined genetic restriction of a non-internal image monoclonal anti-idiotypic vaccine against Semliki Forest virus. Oosterlaken TA; Harmsen M; Ekstijn GL; Kraaijeveld CA; Snippe H Immunology; 1992 Feb; 75(2):224-31. PubMed ID: 1551685 [TBL] [Abstract][Full Text] [Related]
6. The effect of acetylethyleneimine upon a strain of inactivated foot-and-mouth disease virus stored at 4 degrees C. Staple RF; Morrow AW; Fletton BW Arch Virol; 1975; 47(4):331-5. PubMed ID: 166627 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of acetylethyleneimine-killed bovine viral diarrhea-mucosal disease virus (BVD) vaccine for prevention of BVD infection of the fetus. McClurkin AW; Coria MF; Smith RL Proc Annu Meet U S Anim Health Assoc; 1975; (79):114-23. PubMed ID: 220623 [No Abstract] [Full Text] [Related]
8. Structure and immunogenicity of experimental foot-and-mouth disease and poliomyelitis vaccines. Twomey T; Newman J; Burrage T; Piatti P; Lubroth J; Brown F Vaccine; 1995 Nov; 13(16):1603-10. PubMed ID: 8578849 [TBL] [Abstract][Full Text] [Related]
9. Chikungunya, Influenza, Nipah, and Semliki Forest Chimeric Viruses with Vesicular Stomatitis Virus: Actions in the Brain. van den Pol AN; Mao G; Chattopadhyay A; Rose JK; Davis JN J Virol; 2017 Mar; 91(6):. PubMed ID: 28077641 [TBL] [Abstract][Full Text] [Related]
10. Semliki Forest virus E2 envelope epitopes induce a nonneutralizing humoral response which protects mice against lethal challenge. Grosfeld H; Velan B; Leitner M; Cohen S; Lustig S; Lachmi BE; Shafferman A J Virol; 1989 Aug; 63(8):3416-22. PubMed ID: 2473217 [TBL] [Abstract][Full Text] [Related]
11. Recombinant Semliki Forest virus particles expressing louping ill virus antigens induce a better protective response than plasmid-based DNA vaccines or an inactivated whole particle vaccine. Fleeton MN; Liljeström P; Sheahan BJ; Atkins GJ J Gen Virol; 2000 Mar; 81(Pt 3):749-58. PubMed ID: 10675413 [TBL] [Abstract][Full Text] [Related]
12. Inactivation and reactivation of Semliki Forest virus by urea and guanidine hydrochloride. Fleming P J Gen Virol; 1971 Dec; 13(3):393-400. PubMed ID: 5168571 [No Abstract] [Full Text] [Related]
13. Production of defective interfering virus in the brains of mice by an avirulent, in contrast with a virulent, strain of Semliki forest virus. Woodward CG; Smith H Br J Exp Pathol; 1975 Aug; 56(4):363-72. PubMed ID: 1174462 [TBL] [Abstract][Full Text] [Related]
14. Immunogenicity and protective efficacy of Semliki forest virus replicon-based DNA vaccines encoding goatpox virus structural proteins. Zheng M; Jin N; Liu Q; Huo X; Li Y; Hu B; Ma H; Zhu Z; Cong Y; Li X; Jin M; Zhu G Virology; 2009 Aug; 391(1):33-43. PubMed ID: 19559453 [TBL] [Abstract][Full Text] [Related]
15. Immune responses in mice vaccinated with a suicidal DNA vaccine expressing the hemagglutinin glycoprotein from the peste des petits ruminants virus. Wang Y; Liu G; Shi L; Li W; Li C; Chen Z; Jin H; Xu B; Li G J Virol Methods; 2013 Nov; 193(2):525-30. PubMed ID: 23896018 [TBL] [Abstract][Full Text] [Related]
16. Structural differences between foot-and-mouth disease and poliomyelitis viruses influence their inactivation by aziridines. Burrage T; Kramer E; Brown F Vaccine; 2000 May; 18(22):2454-61. PubMed ID: 10738103 [TBL] [Abstract][Full Text] [Related]
17. Plating efficiency of Semliki Forest virus; influence of caseinase C treatment of the virus. Osterrieth PM Acta Virol; 1966 Nov; 10(6):496-505. PubMed ID: 4381985 [No Abstract] [Full Text] [Related]
18. [The antibody titer and fluorescence suitability of semliki forest virus immune sera (author's transl)]. Weiland E Zentralbl Bakteriol Orig A; 1974; 229(1):37-44. PubMed ID: 4155207 [No Abstract] [Full Text] [Related]
19. Virulence of a mouse-adapted Semliki Forest virus strain is associated with reduced susceptibility to interferon. Deuber SA; Pavlovic J J Gen Virol; 2007 Jul; 88(Pt 7):1952-1959. PubMed ID: 17554028 [TBL] [Abstract][Full Text] [Related]
20. Identification of linear epitopes on Semliki Forest virus E2 membrane protein and their effectiveness as a synthetic peptide vaccine. Snijders A; Benaissa-Trouw BJ; Oosterlaken TA; Puijk WC; Posthumus WP; Meloen RH; Boere WA; Oosting JD; Kraaijeveld CA; Snippe H J Gen Virol; 1991 Mar; 72 ( Pt 3)():557-65. PubMed ID: 1706409 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]